INTEGRA LIFESCIENCES HOLDINGS CORP (IART) Gross Margin
- Gross margin · 12 months: Value (m); Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | (m) | Gross profit / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | (m) | Gross Profit |
| Revenue | 1.65B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 783.08M USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | (m) | $1.65B | $783.08M | (m) |
| 2026-03-31 | (m) | $1.64B | $790.34M | (m) |
| 2025-12-31 | (m) | $1.64B | $803.63M | (m) |
| 2025-09-30 | (m) | $1.64B | $783.14M | (m) |
| 2025-06-30 | (m) | $1.62B | $768.66M | (m) |
| 2025-03-31 | (m) | $1.62B | $754.65M | (m) |
| 2024-12-31 | (m) | $1.61B | $728.47M | (m) |
| 2024-09-30 | (m) | $1.56B | $705.44M | (m) |
| 2024-06-30 | (m) | $1.57B | $688.92M | (m) |
| 2024-03-31 | (m) | $1.53B | $670.90M | (m) |
| 2023-12-31 | (m) | $1.54B | $656.84M | (m) |
| 2023-09-30 | (m) | $1.54B | $634.23M | (m) |
| 2023-06-30 | (m) | $1.55B | $618.60M | (m) |
| 2023-03-31 | (m) | $1.56B | $592.76M | (m) |
| 2022-12-31 | (m) | $1.56B | $587.36M | (m) |
| 2022-09-30 | (m) | $1.57B | $595.67M | (m) |
| 2022-06-30 | (m) | $1.57B | $591.69M | (m) |
| 2022-03-31 | (m) | $1.56B | $594.55M | (m) |
| 2021-12-31 | (m) | $1.54B | $597.81M | (m) |
| 2021-09-30 | (m) | $1.53B | $588.63M | (m) |
| 2021-06-30 | (m) | $1.51B | $578.97M | (m) |
| 2021-03-31 | (m) | $1.38B | $533.18M | (m) |
| 2020-12-31 | $851.03M | $1.37B | $520.83M | 62.03% |
| 2020-09-30 | (m) | $1.38B | $523.23M | (m) |
| 2020-06-30 | (m) | $1.39B | $531.05M | (m) |
| 2020-03-31 | (m) | $1.51B | $569.25M | (m) |
| 2019-12-31 | $952.88M | $1.52B | $564.68M | 62.79% |
| 2019-09-30 | (m) | $1.51B | $561.68M | (m) |
| 2019-06-30 | (m) | $1.49B | $562.29M | (m) |
| 2019-03-31 | (m) | $1.48B | $556.19M | (m) |
| 2018-12-31 | $900.95M | $1.47B | $571.50M | 61.19% |
| 2018-09-30 | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | (m) | (m) | (m) |
| 2017-12-31 | $752.73M | (m) | (m) | (m) |
| 2017-09-30 | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | (m) | (m) | (m) |
| 2016-12-31 | $642.99M | (m) | (m) | (m) |
| 2016-09-30 | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | (m) | (m) | (m) |
| 2015-12-31 | $556.19M | (m) | (m) | (m) |
| 2015-09-30 | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | (m) | (m) | (m) |
| 2014-12-31 | $575.50M | (m) | (m) | (m) |
| 2014-09-30 | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | (m) | (m) | (m) |
| 2013-12-31 | $502.13M | (m) | (m) | (m) |
| 2013-09-30 | (m) | (m) | (m) | (m) |
| 2013-06-30 | $501.90M | (m) | (m) | (m) |
| 2013-03-31 | $511.32M | (m) | (m) | (m) |
| 2012-12-31 | $516.44M | (m) | (m) | (m) |
| 2012-09-30 | $504.73M | (m) | (m) | (m) |
| 2012-06-30 | $497.72M | (m) | (m) | (m) |
| 2012-03-31 | $486.32M | (m) | (m) | (m) |
| 2011-12-31 | $480.93M | (m) | (m) | (m) |
| 2011-09-30 | $482.97M | (m) | (m) | (m) |
| 2011-06-30 | $476.89M | (m) | (m) | (m) |
| 2011-03-31 | $470.53M | (m) | (m) | (m) |
| 2010-12-31 | $463.88M | (m) | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) |
| 2010-03-31 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |